FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
DTIC-DOME
dacarbazine
LOE Approaching
Bayer
INJECTION · INJECTABLE
the treatment of metastatic malignant melanomamelanoma
1975
NDA30/100
DUAC
benzoyl peroxide; clindamycin phosphate
LOE Approaching
GSK
TOPICAL · GEL
2002
NDA30/100
DULERA
mometasone furoate and formoterol fumarate dihydrate
LOE Approaching
Merck & Co.
INHALATION · AEROSOL, METERED
asthma
2010
NDA30/100
DULOXETINE
duloxetine
Launch
Almatica Pharma
CAPSULE, DELAYED RELEASE
the following conditions: Major depressive disorder (MDD) in adults ( ) Generalized anxiety disorder (GAD) in adultsolder ( ) Diabetic peripheral neuropathic pain (DPNP) in adults ( ) Fibromyalgia (FM) in adults+2
2026
NDA30/100
DUO-MEDIHALER
isoproterenol hydrochloride; phenylephrine bitartrate
LOE Approaching
INHALATION · AEROSOL, METERED
To improve hemodynamic status
1973
NDA30/100
DUOCAINE
bupivacaine hydrochloride; lidocaine hydrochloride
LOE Approaching
R-Pharm US
INJECTION · INJECTABLE
regional anesthesiaanalgesia for surgery+5
2003
NDA30/100
DUODOTE
atropine and pralidoxime chloride
LOE Approaching
Medcaptain Medical Technology
INTRAMUSCULAR · INJECTABLE
poisoning by organophosphorus nerve agents
2006
NDA30/100
DUONEB
albuterol sulfate; ipratropium bromide
LOE Approaching
INHALATION · SOLUTION
2001
NDA30/100
DUOPA
carbidopa and levodopa
Peak
AbbVie
ENTERAL · SUSPENSION
motor fluctuations in patients with advanced Parkinson's disease ()Parkinson's disease
2015
NDA30/100
DURABOLIN
nandrolone phenpropionate
LOE Approaching
Merck & Co.
INJECTION · INJECTABLE
1959
NDA30/100
DURACLON
clonidine hydrochloride
LOE Approaching
Viatris (2)
INJECTION · INJECTABLE
combination with opiates for the treatment of severe pain in cancer patients
1996
NDA30/100
DURAGESIC-100
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAGESIC-12
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAGESIC-25
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAGESIC-37
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAGESIC-50
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAGESIC-75
fentanyl
LOE Approaching
Johnson & Johnson
TRANSDERMAL · FILM, EXTENDED RELEASE
severepersistent pain in opioid-tolerant patients+1
1990
NDA30/100
DURAMORPH PF
morphine sulfate
LOE Approaching
Hikma
INJECTION · INJECTABLE
chronic pain
1984
NDA30/100
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
LOE Approaching
AstraZeneca
INJECTION · INJECTABLE
regional anesthesiaanalgesia for surgery+5
1976
NDA30/100
DURANEST
epinephrine bitartrate; etidocaine hydrochloride
LOE Approaching
INJECTION · INJECTABLE
regional anesthesiaanalgesia for surgery+5
1976
NDA30/100
DURAPREP
iodine povacrylex and isopropyl alcohol
LOE Approaching
TOPICAL · SPONGE
bacteria
2006
NDA30/100
DUREZOL
difluprednate ophthalmic
LOE Approaching
Novartis
OPHTHALMIC · EMULSION
inflammationpain associated with ocular surgery+1
2008
NDA30/100
DURICEF
cefadroxil/cefadroxil hemihydrate
LOE Approaching
AbbVie
ORAL · FOR SUSPENSION
1980
NDA30/100
DURICEF
cefadroxil/cefadroxil hemihydrate
LOE Approaching
AbbVie
ORAL · TABLET
1980
NDA30/100